Merkel Cell Carcinoma of the Penis
Primary Site | Histology | Staging Type |
---|---|---|
C600-C602, C608-C609 | 8247 | TNM 7 and Summary Stage |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C600 Prepuce C601 Glans penis C602 Body of penis C608 Overlapping lesion of penis C609 Penis, NOS **Note 1:** This schema is based on the UICC chapter *Merkel Cell Carcinoma of Skin,* pages 177-180. * These primary sites are not listed in this chapter of the UICC manual; however, they are included in this schema and TNM staged **Note 2:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Skin Except Eyelid* chapter on page 172 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=172).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes |
NAACCR #940
tnmClinT |
None | |
Clinical N | <BLANK> | Yes |
NAACCR #950
tnmClinN |
None | |
Clinical M | <BLANK> | Yes |
NAACCR #960
tnmClinM |
None | |
TNM Clin Stage Group | 99 | Yes |
NAACCR #970
tnmClinStageGroup |
None | |
Pathologic T | <BLANK> | Yes |
NAACCR #880
tnmPathT |
None | |
Pathologic N | <BLANK> | Yes |
NAACCR #890
tnmPathN |
None | |
Pathologic M | <BLANK> | Yes |
NAACCR #900
tnmPathM |
None | |
TNM Path Stage Group | 99 | Yes |
NAACCR #910
tnmPathStageGroup |
None | |
SSF1: Measured Thickness (Depth) | 988 | No |
NAACCR #2880
csSiteSpecificFactor1 |
CCCR/Canada COC |
None |
SSF16: Size of Metastasis in Lymph Nodes | 999 | No |
NAACCR #2870
csSiteSpecificFactor16 |
CCCR/Canada COC SEER |
None |
SSF17: Extracapsular Extension of Regional Lymph Nodes | 999 | No |
NAACCR #2871
csSiteSpecificFactor17 |
CCCR/Canada COC SEER |
None |
SSF18: Isolated Tumor Cells (ITC) in Regional Lymph Node(s) | 999 | No |
NAACCR #2872
csSiteSpecificFactor18 |
CCCR/Canada COC SEER |
None |
SSF19: Tumor Base Transection Status | 988 | No |
NAACCR #2873
csSiteSpecificFactor19 |
None | None |
SSF20: Tumor Infiltrating Lymphocytes (TIL) | 988 | No |
NAACCR #2874
csSiteSpecificFactor20 |
None | None |
SSF21: Growth Pattern of Primary Tumor | 988 | No |
NAACCR #2875
csSiteSpecificFactor21 |
None | None |
SSF22: Profound Immune Suppression | 999 | No |
NAACCR #2876
csSiteSpecificFactor22 |
CCCR/Canada COC SEER |
None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes |
NAACCR #1380
rxSummSurgRadSeq |
None | |
Regional Nodes Positive | <BLANK> | Yes |
NAACCR #820
regionalNodesPositive |
None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
derivedSeerClinStgGrp |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
derivedSeerPathStgGrp |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
derivedSeerCmbStgGrp |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
derivedSeerCombinedT |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
derivedSeerCombinedN |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
derivedSeerCombinedM |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
derivedSeerCmbTSrc |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
derivedSeerCmbNSrc |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
derivedSeerCmbMSrc |
None |